Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adaptive Biotechnologies Corporation    ADPT

ADAPTIVE BIOTECHNOLOGIES CORPORATION

(ADPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form 8-K)

03/05/2021 | 08:13am EDT

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 11, 2021, the Compensation Committee of the Board of Directors of Adaptive Biotechnologies Corporation (the "Company") determined to begin granting restricted stock units ("RSUs") to the Company's executive officers, to be first granted on March 4, 2021 (the "Grant Date"). Each RSU represents a right to receive one share of the Company's common stock upon vesting. The RSUs vest in 25% increments on each of the first four anniversaries of the Grant Date. The RSUs granted to each of the Company's named executive officers on March 4, 2021 are set forth below.





                             RSUs Granted
Name and Principal Position      (#)
Chad Robins                      68,691
Chief Executive Officer

Lance Baldo                      22,894
Chief Medical Officer

Harlan Robins                    68,691
Chief Scientific Officer



The foregoing is a summary only and does not purport to be a complete description of all of the terms and provisions of the RSUs, and is subject to and qualified by reference to the full text of the Company's 2019 Equity Incentive Plan and the form of RSU Award Agreement thereunder, each of which have been filed as Exhibit 10.14 to the Company's Form 10-K, dated February 24, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about ADAPTIVE BIOTECHNOLOGIES CORPORATION
03/17ADAPTIVE BIOTECHNOLOGIES CORP  : Change in Directors or Principal Officers, Regu..
AQ
03/17Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Dire..
GL
03/08SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Monday
MT
03/08SECTOR UPDATE : Health Care
MT
03/08ADAPTIVE BIOTECHNOLOGIES  : Secures FDA Emergency Use Authorization For T-Cell-B..
MT
03/05ADAPTIVE BIOTECHNOLOGIES  : Gets FDA EUA for T-Detect to Confirm Recent or Prior..
DJ
03/05Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Dete..
GL
03/05ADAPTIVE BIOTECHNOLOGIES CORP  : Change in Directors or Principal Officers (form..
AQ
03/03ADAPTIVE BIOTECHNOLOGIES  : Goldman Sachs Downgrades Adaptive Biotechnologies to..
MT
03/02ADAPTIVE BIOTECHNOLOGIES CORP  : Regulation FD Disclosure, Other Events (form 8-..
AQ
More news